CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-27 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,364 | 0 | ||
| 2024-03-27 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion 10b5-1 | +5,184 | 237,188 | ||
| 2024-03-27 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion · Restricted Stock Unit 10b5-1 | −5,184 | 0 | ||
| 2024-03-27 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +2,292 | 72,938 | ||
| 2024-03-27 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −2,292 | 0 | ||
| 2024-03-15 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −10,265 | $87.98 | $903K | 40,645 |
| 2024-03-15 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −20,575 | $88.97 | $1.8M | 20,070 |
| 2024-03-15 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −20,070 | $89.60 | $1.8M | 0 |
| 2024-03-15 | BOTHA ROELOF Director | Exercise or conversion | +424 | $67.37 | $29K | 776 |
| 2024-03-15 | BOTHA ROELOF Director | Exercise or conversion | +735 | $42.86 | $32K | 1,511 |
| 2024-03-15 | BOTHA ROELOF Director | Exercise or conversion | +14,136 | $41.19 | $582K | 15,647 |
| 2024-03-15 | BOTHA ROELOF Director | Exercise or conversion | +884 | $40.48 | $36K | 16,531 |
| 2024-03-15 | BOTHA ROELOF Director | Exercise or conversion | +851 | $41.51 | $35K | 17,382 |
| 2024-03-15 | BOTHA ROELOF Director | Exercise or conversion | +793 | $41.82 | $33K | 18,175 |
| 2024-03-15 | BOTHA ROELOF Director | Exercise or conversion | +607 | $51.40 | $31K | 18,782 |
| 2024-03-15 | BOTHA ROELOF Director | Exercise or conversion | +687 | $45.88 | $32K | 19,469 |
| 2024-03-15 | BOTHA ROELOF Director | Exercise or conversion | +807 | $38.26 | $31K | 20,276 |
| 2024-03-15 | BOTHA ROELOF Director | Exercise or conversion · Stock Option (right to buy) | −424 | 0 | ||
| 2024-03-15 | BOTHA ROELOF Director | Exercise or conversion · Stock Option (right to buy) | −735 | 0 | ||
| 2024-03-15 | BOTHA ROELOF Director | Exercise or conversion · Stock Option (right to buy) | −14,136 | 0 |
Page 76 of 85 · 1,682 trades